Articles

Endocyte shares plunge on clinical trial results

Shares of Endocyte Inc. plummeted more than 60 percent Tuesday morning after clinical trial results showed the company’s experimental ovarian cancer drug led to shorter survival times than treatment with a standard cancer drug.

Read More

Third-quarter profit dips at OneAmerica

OneAmerica earned $15.4 million in the three months ended Sept. 30, down 53 percent from the same quarter a year ago. Most of that difference came from a 17-percent jump in policy benefit payments.

Read More

Q&A

Carmel resident David Wasilewski has launched WhatNext, a website that uses algorithms to make it easier for cancer patients to connect with others in similar circumstances. Wasilewski, 39, spent eight years as chief operating officer of the Spanx line of body shapers and did health care consulting before that. In addition to helping patients, he thinks WhatNext can become a way for health care organizations share their expertise with patients in need.

Read More

Mills: Health care’s future is partnership

In spite of all the consolidation lately among hospitals, Community Health CEO Bryan Mills says the future of hospital systems will hinge more on partnerships like the one Community struck last week on its rehab hospital.

Read More

Brokers’ hopes dashed by feds

The Obama administration on Friday let stand an earlier rule that said brokers’ fees will have to count toward a 15-percent to 20-percent cap on administrative expenses placed on insurance plans by the 2010 health overhaul.

Read More

States suing over health care law collect funding

Federal officials announced Tuesday they are awarding more money to help states carry out President Barack Obama's health care overhaul. Seven states that are suing to overturn the landmark law are also on the list for funding.

Read More

IU Health reports most serious medical errors

Indiana’s largest and busiest medical system committed 19 preventable errors last year at its hospitals in Indianapolis and other cities, three fewer than in 2009, according to a report released Monday.

Read More

Drugmakers, pharmacists at odds

Indianapolis-based Eli Lilly and Co. recently rejected CVS Caremark’s demands for big price discounts on its insulins, leading CVS to kick Lilly’s insulins off its list of recommended drugs.

Read More

Brokers get hope on commissions

The National Association of Insurance Commissioners passed a resolution Nov. 22 that urges Congress and the Obama administration to exclude benefits brokers’ commissions from the new requirement that insurers spend only 15 percent to 20 percent of the premiums they collect on administration and profits.

Read More

Health insurers push comparison shopping

Indianapolis-based Anthem Blue Cross and Blue Shield and Minnesota-based UnitedHealthcare say they’re responding to demands from employers, who are desperate to rein in spiraling health benefits costs and have begun embracing the idea that to do so they must change their workers’ approach to health and health care.

Read More